FAQs What NAD supplement does Gary Brecka take
It is being developed by Eli Lilly and Company and is currently undergoing Phase 3 clinical trials, which are necessary to establish long-term safety, efficacy, and optimal dosing in larger, more diverse populations before a regulatory submission can be made
Moreover, whereas existing formulations have enhanced convenience via weekly dosing and oral preparations, there is potential for innovation in delivery methods to increase patient adherence and comfort
Two are still open: TRIUMPH-7 (NCT07035093), for obesity or overweight with chronic low back pain, and the Phase 3 multi-agent MASLD master protocol (NCT07165028), which studies several drugs rather than retatrutide alone
Children: 1/4 teaspoon for every 30 lb
Without adequate phosphatidylcholine, fat and cholesterol accumulate in the liver (see Deficiency)